Will Japan Pharma Fall In Line With R&D Externalization Trends?
Executive Summary
Japanese pharma companies are generally following the same trends as their global counterparts when it comes to the externalization of R&D, and revenues from internal projects are set to fall over the next few years, with Takeda in particular expected to look much more to external opportunities.